The DOI matches its Crossref record; 360 of the 360 references it cites were found in a registry or an index.
Chemistry in human telomere biology: structure, function and targeting of telomere DNA/RNA
Abstract
Telomeres are present at the ends of all eukaryotic chromosomes. Human telomeres play an important role in critical processes underlying genome stability, cancer, and aging, and their importance was recognized via the award of the 2009 Nobel Prize in Physiology or Medicine. Chemistry has made vast and almost unparalleled contributions to telomere biology. This critical review highlights the contributions of chemistry in human telomeres and summarizes the significant development of human telomere biology. First, I provide an overview of the advances in understanding of the structures and functions of human telomeres. Second, I focus on the current efforts on developing various chemical approaches to targeting human telomeres and telomerase for the treatment of cancer. Third, studies on a newly discovered telomeric repeat-containing RNA are discussed in detail. Last, future challenges in the field are outlined, including perspectives of both chemistry and biology (412 references).
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–360 of 360
G-Quadruplex Formation by Human Telomeric Repeats-Containing RNA in Na+ Solution
Xu, Y., Kaminaga, K., & Komiyama, M. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8031532 · Cited by 183
Self-citationChiral metallo-supramolecular complexes selectively recognize human telomeric G-quadruplex DNA
Yu, H., Wang, X., Fu, M., Ren, J., & Qu, X. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn569 · Cited by 182
Parkinson, G. N., Cuenca, F., & Neidle, S. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.06.022 · Cited by 175
Selective Recognition of G-Quadruplex Telomeric DNA by a Bis(quinacridine) Macrocycle
Teulade-Fichou, M.-P., Carrasco, C., Guittat, L., Bailly, C., Alberti, P., Mergny, J.-L., David, A., Lehn, J.-M., & Wilson, W. D. (2003) · Journal of the American Chemical Society · doi:10.1021/ja021299j · Cited by 174
Macrocyclic and Helical Oligoamides as a New Class of G-Quadruplex Ligands
Shirude, P. S., Gillies, E. R., Ladame, S., Godde, F., Shin-ya, K., Huc, I., & Balasubramanian, S. (2007) · Journal of the American Chemical Society · doi:10.1021/ja073775h · Cited by 171
Guanine tetraplex topology of human telomere DNA is governed by the number of (TTAGGG) repeats
Vorlickova, M. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki898 · Cited by 171
White, L. K., Wright, W. E., & Shay, J. W. (2001) · Trends in Biotechnology · doi:10.1016/s0167-7799(00)01541-9 · Cited by 171
Cellular delivery of peptide nucleic acids and inhibition of human telomerase
Hamilton, S. E., Simmons, C. G., Kathiriya, I. S., & Corey, D. R. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80046-5 · Cited by 170
Rujan, I. N. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki345 · Cited by 168
Telomerase and ATM/Tel1p Protect Telomeres from Nonhomologous End Joining
Chan, S. W.-L., & Blackburn, E. H. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00174-6 · Cited by 168
Human telomerase inhibition by substituted acridine derivatives
Harrison, R. J., Gowan, S. M., Kelland, L. R., & Neidle, S. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00394-7 · Cited by 161
Human diseases of telomerase dysfunction: insights into tissue aging
Garcia, C. K., Wright, W. E., & Shay, J. W. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm644 · Cited by 161
Telomerase in the early detection of cancer.
Shay, J. W., & Gazdar, A. F. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.2.106 · Cited by 160
Evidence that exposure of the telomere 3′ overhang sequence induces senescence
Li, G.-Z., Eller, M. S., Firoozabadi, R., & Gilchrest, B. A. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0235444100 · Cited by 160
Functional and dysfunctional roles of quadruplex DNA in cells
Arthanari, H., & Bolton, P. H. (2001) · Chemistry & Biology · doi:10.1016/s1074-5521(01)00007-2 · Cited by 160
Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532
Eldaly, H., Kull, M., Zimmermann, S., Pantić, M., Waller, C. F., & Martens, U. M. (2004) · Blood · doi:10.1182/blood-2003-12-4322 · Cited by 160
Zhong, Z.-H., Jiang, W.-Q., Cesare, A. J., Neumann, A. A., Wadhwa, R., & Reddel, R. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m701413200 · Cited by 159
Incles, C. M., Schultes, C. M., Kempski, H., Koehler, H., Kelland, L. R., & Neidle, S. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1201.3.10 · Cited by 158
TERRA transcripts are bound by a complex array of RNA-binding proteins
de Silanes, I. L., d’Alcontres, M. S., & Blasco, M. A. (2010) · Nature Communications · doi:10.1038/ncomms1032 · Cited by 157
Gabelica, V., Baker, E. S., Teulade‐Fichou, M., Pauw, E. D., & Bowers, M. T. (2007) · Journal of the American Chemical Society · doi:10.1021/ja065989p · Cited by 157
Collie, G. W., Parkinson, G. N., Neidle, S., Rosu, F., Pauw, E. D., & Gabelica, V. (2010) · Journal of the American Chemical Society · doi:10.1021/ja100345z · Cited by 156
Read, M. A., Wood, A. A., Harrison, J. R., Gowan, S. M., Kèlland, L. R., Dosanjh, H. S., & Neidle, S. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990287e · Cited by 155
Ueno, T., Takahashi, H., Oda, M., Mizunuma, M., Yokoyama, A., Goto, Y., Mizushina, Y., Sakaguchi, K., & Hayashi, H. (2000) · Biochemistry · doi:10.1021/bi992661i · Cited by 154
Djojosubroto, M. W., Chin, A. C., Go, N., Schaetzlein, S., Manns, M. P., Gryaznov, S., Harley, C. B., & Rudolph, L. K. (2005) · Hepatology · doi:10.1002/hep.20822 · Cited by 151
Tri- and tetra-substituted naphthalene diimides as potent G-quadruplex ligands
Cuenca, F., Greciano, O., Gunaratnam, M., Haider, S. M., Munnur, D., Nanjunda, R. K., Wilson, W. D., & Neidle, S. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.01.050 · Cited by 151
TERRA biogenesis, turnover and implications for function
Feuerhahn, S., Iglesias, N., Panza, A., Porro, A., & Lingner, J. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.07.032 · Cited by 151
Leonetti, C., Amodei, S., D’Angelo, C., Rizzo, A., Benassi, B., Antonelli, A., Elli, R., Stevens, M. F. G., D’Incalci, M., Zupi, G., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001537 · Cited by 150
Telomeres and telomerases as drug targets
Rezler, E. M., Bearss, D. J., & Hurley, L. H. (2002) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(02)00182-0 · Cited by 147
Hochreiter, A. E., Xiao, H., Goldblatt, E. M., Gryaznov, S. M., Miller, K. D., Badve, S., Sledge, G. W., & Herbert, B.-S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2760 · Cited by 146
Freyer, M. W., Buscaglia, R., Kaplan, K. A., Cashman, D. J., Hurley, L. H., & Lewis, E. A. S. (2006) · Biophysical Journal · doi:10.1529/biophysj.106.097246 · Cited by 146
Mechanism of acridine-based telomerase inhibition and telomere shortening
Gunaratnam, M., Greciano, O., Martins, C., Reszka, A. P., Schultes, C. M., Morjani, H., Riou, J., & Neidle, S. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.011 · Cited by 145
Inhibition of human telomerase by 2′- O -methyl-RNA
Pitts, A. E., & Corey, D. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11549 · Cited by 144
Quinone Methides Tethered to Naphthalene Diimides as Selective G-Quadruplex Alkylating Agents
Antonio, M. D., Doria, F., Richter, S. N., Bertipaglia, C., Mella, M., Sissi, C., Palumbo, M., & Freccero, M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja904876q · Cited by 143
MLL Associates with Telomeres and Regulates Telomeric Repeat-Containing RNA Transcription
Caslini, C., Connelly, J. A., Serna, A. N., Broccoli, D., & Hess, J. L. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00195-09 · Cited by 142
Kim, M. M., Rivera, M. A., Botchkina, I. L., Shalaby, R., Thor, A. D., & Blackburn, E. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131211098 · Cited by 140
Inhibition of Telomerase Activity by PKC Inhibitors in Human Nasopharyngeal Cancer Cells in Culture
Ku, W., Cheng, A., & Wang, T. V. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7874 · Cited by 138
Xu, Y., Ishizuka, T., Kurabayashi, K., & Komiyama, M. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200903858 · Cited by 136
Self-citationPOT1b protects telomeres from end‐to‐end chromosomal fusions and aberrant homologous recombination
He, H., Multani, A. S., Cosme‐Blanco, W., Tahara, H., Ma, J., Pathak, S., Deng, Y., & Chang, S. S. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601294 · Cited by 136
Telomerase inhibition by peptide nucleic acids reverses `immortality' of transformed human cells
Shammas, M. A., Simmons, C. G., Corey, D. R., & Shmookler Reis, R. J. (1999) · Oncogene · doi:10.1038/sj.onc.1203069 · Cited by 135
Interaction of Telomestatin with the Telomeric Single-strand Overhang
Gómez, D., Boujemaa‐Paterski, R., Lemarteleur, T., Shin‐ya, K., Mergny, J., & Riou, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406123200 · Cited by 134
Recombinational Telomere Elongation Promoted by DNA Circles
Natarajan, S., & McEachern, M. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.13.4512-4521.2002 · Cited by 133
Seimiya, H., Oh‐hara, T., Suzuki, T., Naasani, I., Shimazaki, T., Tsuchiya, K., & Tsuruo, T. (2002) · PubMed · Cited by 133
Human Telomere Structure and Biology
Riethman, H. C. (2008) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.8.021506.172017 · Cited by 130
Ligand‐Driven G‐Quadruplex Conformational Switching By Using an Unusual Mode of Interaction
Rodriguez, R., Pantoş, G. D., Gonçalves, D. P. N., Sanders, J. K. M., & Balasubramanian, S. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200605075 · Cited by 130
Marrone, A., Stevens, D., Vulliamy, T., Dokal, I. S., & Mason, P. J. (2004) · Blood · doi:10.1182/blood-2004-05-1829 · Cited by 129
Petraccone, L., Trent, J. O., & Chaires, J. B. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8075567 · Cited by 128
Telomere Inhibition and Telomere Disruption as Processes for Drug Targeting
Rezler, E. M., Bearss, D. J., & Hurley, L. H. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135733 · Cited by 126
Oxazole-Based Peptide Macrocycles: A New Class of G-Quadruplex Binding Ligands
Jantos, K., Rodriguez, R., Ladame, S., Shirude, P. S., & Balasubramanian, S. (2006) · Journal of the American Chemical Society · doi:10.1021/ja064713e · Cited by 126
Effects of a novel telomerase inhibitor, GRN163L, in human breast cancer
Gellert, G. C., Dikmen, Z. G., Wright, W. E., Gryaznov, S. M., & Shay, J. W. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9043-5 · Cited by 126
Redon, S. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg259 · Cited by 125
The Role of the Nonhomologous End-Joining DNA Double-Strand Break Repair Pathway in Telomere Biology
Říha, K., Heacock, M. L., & Shippen, D. E. (2006) · Annual Review of Genetics · doi:10.1146/annurev.genet.39.110304.095755 · Cited by 122
Heald, R. A., Modi, C., Cookson, J. C., Hutchinson, I. S., Laughton, C. A., Gowan, S. M., Kèlland, L. R., & Stevens, M. F. G. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm011015q · Cited by 120
(3 + 1) Assembly of Three Human Telomeric Repeats into an Asymmetric Dimeric G-Quadruplex
Zhang, N., Phan, A. T., & Patel, D. J. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0543090 · Cited by 120
The effects of nucleoside analogs on telomerase and telomeres inTetrahymena
Strahl, C., & Blackburn, E. H. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.6.893 · Cited by 120
G‐Quadruplex Recognition by Quinacridines: a SAR, NMR, and Biological Study
Hounsou, C., Guittat, L., Monchaud, D., Jourdan, M., Saettel, N., Mergny, J., & Teulade‐Fichou, M. (2007) · ChemMedChem · doi:10.1002/cmdc.200600286 · Cited by 118
Telomerase inhibition as cancer therapy
Saretzki, G. C. (2003) · Cancer Letters · doi:10.1016/s0304-3835(02)00708-5 · Cited by 115
Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors
Olivero, O. A. (2006) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20195 · Cited by 115
Intramolecular quadruplex conformation of human telomeric DNA assessed with 125I-radioprobing
He, Y. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh875 · Cited by 114
Bolonaki, I., Kotsakis, A. P., Papadimitraki, E., Aggouraki, D., Konsolakis, G., Vagia, A., Christophyllakis, C., Nikoloudi, I., Magganas, E., Galanis, A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3465 · Cited by 113
NMR studies on truncated sequences of human telomeric DNA: observation of a novel A-tetrad
Patel, P. K. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.19.3836 · Cited by 107
Rational Design of Acridine-Based Ligands with Selectivity for Human Telomeric Quadruplexes
Sparapani, S., Haider, S. M., Doria, F., Gunaratnam, M., & Neidle, S. (2010) · Journal of the American Chemical Society · doi:10.1021/ja1003944 · Cited by 106
Domchek, S. M., Recio, A., Mick, R., Clark, C. E., Carpenter, E. L., Fox, K. R., DeMichele, A. M., Schuchter, L. M., Leibowitz, M. S., Wexler, M. H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2765 · Cited by 103
Major cutbacks at chromosome ends
Lansdorp, P. M. (2005) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.05.004 · Cited by 101
Cookson, J. C., Dai, F., Smith, V., Heald, R. A., Laughton, C. A., Stevens, M. F. G., & Burger, A. M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.013300 · Cited by 98
Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component
Kondo, Y., Koga, S., Komata, T., & Kondo, S. (2000) · Oncogene · doi:10.1038/sj.onc.1203538 · Cited by 98
Williamson, J. R. (1993) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(05)80106-x · Cited by 97
Shammas, M. A., Koley, H., Batchu, R. B., Bertheau, R. C., Protopopov, A. I., Munshi, N. C., & Goyal, R. K. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-24 · Cited by 96
Guiducci, C., Cerone, M. A., & Bacchetti, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204145 · Cited by 95
Kanazawa, Y., Ohkawa, K., Ueda, K., et al. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1213 · Cited by 93
Gavathiotis, E., Heald, R. A., Stevens, M. F. G., & Searle, M. S. (2001) · Angewandte Chemie International Edition · Cited by 92
Yokoyama, Y., Takahashi, Y., Shinohara, A., Lian, Z., Wan, X., Niwa, K., & Tamaya, T. (1998) · PubMed · Cited by 92
Telomeres, Telomerase, and Human Disease
Artandi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068187 · Cited by 91
The cellular level of telomere dysfunction determines induction of senescence or apoptosis in vivo
Lechel, A., Ande, S., Ju, Z., Plentz, R. R., Schaetzlein, S., Rudolph, C., Wilkens, L., Wiemann, S. U., Saretzki, G. C., Malek, N. P., et al. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400352 · Cited by 91
Molecular “light switch” for G-quadruplexes and i-motif of human telomeric DNA: [Ru(phen)2(dppz)]2+
Shi, S., Zhao, J., Geng, X., Yao, T., Huang, H., Liu, T., Zheng, L., Li, Z., Yang, D., & Ji, L. (2010) · Dalton Transactions · doi:10.1039/b916094a · Cited by 91
Matsugami, A., Xu, Y., Noguchi, Y., Sugiyama, H., & Katahira, M. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05881.x · Cited by 90
Self-citationIsothiazolone Derivatives Selectively Inhibit Telomerase from Human and Rat Cancer Cells in Vitro
Hayakawa, N., Nozawa, K., Ogawa, A., Kato, N., Yoshida, K., Akamatsu, K., Tsuchiya, M., Nagasaka, A., & Yoshida, S. (1999) · Biochemistry · doi:10.1021/bi982829k · Cited by 90
Solution Structure of a Telomeric DNA Complex of Human TRF1
Nishikawa, T., Okamura, H., Nagadoi, A., König, P., Rhodes, D., & Nishimura, Y. (2001) · Structure · doi:10.1016/s0969-2126(01)00688-8 · Cited by 89
Hamilton, S. E., Pitts, A. E., Katipally, R., Jia, X., Rutter, J. P., Davies, B. A., Shay, J. W., Wright, W. E., & Corey, D. R. (1997) · Biochemistry · doi:10.1021/bi970438k · Cited by 88
Synthesis and G-quadruplex stabilizing properties of a series of oxazole-containing macrocycles
Minhas, G. S., Pilch, D. S., Kerrigan, J. E., LaVoie, E. J., & Rice, J. E. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.05.038 · Cited by 84
Gavathiotis, E., & Searle, M. S. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b300845m · Cited by 83
Cyclo[n]pyrroles: Size and Site-Specific Binding to G-Quadruplexes
Baker, E. S., Lee, J. T., Sessler, J. L., & Bowers, M. T. (2006) · Journal of the American Chemical Society · doi:10.1021/ja0564968 · Cited by 83
Structure of Long Telomeric RNA Transcripts
Randall, A., & Griffith, J. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900631200 · Cited by 83
Wang, E. S., Wu, K., Chin, A. C., Chen‐Kiang, S., Pongracz, K., Gryaznov, S. M., & Moore, M. A. S. (2003) · Blood · doi:10.1182/blood-2003-02-0546 · Cited by 83
Telomerase induction in T cells: A cure for aging and disease?
Effros, R. B. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.11.005 · Cited by 82
Ouchi, H., Ishiguro, H., IKEDA, N., Hori, M., Kubota, Y., & Uemura, H. (2005) · International Journal of Urology · doi:10.1111/j.1442-2042.2004.00973.x · Cited by 82
Telomeres and Telomerase: Pharmacological Targets for New Anticancer Strategies?
Pendino, F., Tárkányi, I., Dudognon, C., Hillion, J., Lanotte, M., Aradi, J., & Segal-Bendirdjian, E. (2006) · Current Cancer Drug Targets · doi:10.2174/156800906776056482 · Cited by 80
2-5A antisense telomerase RNA therapy for intracranial malignant gliomas.
Mukai, S., Kondo, Y., Koga, S., Komata, T., Barna, B. P., & Kondo, S. (2000) · PubMed · Cited by 80
Gaynutdinov, T. I., Neumann, R. D., & Panyutin, I. G. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn351 · Cited by 79
Xu, Y., Suzuki, Y., & Komiyama, M. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200806306 · Cited by 78
Self-citation(2010) · Nature Reviews Genetics · doi:10.1038/nrg2761 · Cited by 78
Using Natural Product Inhibitors to Validate Hsp90 as a Molecular Target in Cancer
Neckers, L. (2006) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606777811979 · Cited by 77
Agents that target telomerase and telomeres
Raymond, É., Sun, D., Chen, S. F., Windle, B., & Hoff, D. D. V. (1996) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(96)80068-1 · Cited by 75
Gómez‐Millán, J., Goldblatt, E. M., Gryaznov, S. M., Mendonca, M. S., & Herbert, B. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.09.038 · Cited by 75
Churikov, D., Wei, C., & Price, C. M. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.01011-06 · Cited by 75
Potent Inhibition of Human Telomerase by Nitrostyrene Derivatives
Kim, J., Kim, J. H., Lee, G. E., Lee, J. E., & Chung, I. K. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1117 · Cited by 75
Covalent ligation studies on the human telomere quadruplex
Qi, J. Y. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki632 · Cited by 74
Sissi, C., Lucatello, L., Krapcho, A. P., Maloney, D. J., Boxer, M. B., Camarasa, M. V., Pezzoni, G., Menta, E., & Palumbo, M. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.029 · Cited by 74
2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells.
Kushner, D. M., Paranjape, J. M., Bandyopadhyay, B., Cramer, H., Leaman, D., Kennedy, A., Silverman, R. H., & Cowell, J. K. (2000) · Gynecologic Oncology · doi:10.1006/gyno.1999.5668 · Cited by 74
Potent inhibition of human telomerase by helenalin
Huang, P., Yeh, Y., & Wang, T. V. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.11.045 · Cited by 74
Barbieri, C. M., Srinivasan, A. R., Rzuczek, S. G., Rice, J. E., LaVoie, E. J., & Pilch, D. S. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm188 · Cited by 73
Antiadhesive Effects of GRN163L—An Oligonucleotide N3′→P5′ Thio-Phosphoramidate Targeting Telomerase
Jackson, S. R., Zhu, C.-H., Paulson, V., Watkins, L., Dikmen, Z. G., Gryaznov, S. M., Wright, W. E., & Shay, J. W. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2306 · Cited by 72
Folini, M., Colella, G., Villa, R., Lualdi, S., Daidone, M. G., & Zaffaroni, N. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00870.x · Cited by 72
Martins, C., Gunaratnam, M., Stuart, J. W., Makwana, V., Greciano, O., Reszka, A. P., Kèlland, L. R., & Neidle, S. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.056 · Cited by 71
Is Telomerase a Universal Cancer Target?
Morin, G. B. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.12.859 · Cited by 70
Telomeres and Telomerase: From Discovery to Clinical Trials
Corey, D. R. (2009) · Chemistry & Biology · doi:10.1016/j.chembiol.2009.12.001 · Cited by 69
Synthesis of a Potent G‐Quadruplex‐Binding Macrocyclic Heptaoxazole
Tera, M., Iida, K., Ishizuka, H., Takagi, M., Suganuma, M., Doi, T., Shin‐ya, K., & Nagasawa, K. (2009) · ChemBioChem · doi:10.1002/cbic.200800563 · Cited by 68
Murakami, J., Nagai, N., Shigemasa, K., & Ohama, K. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00037-4 · Cited by 68
Riou, J. (2004) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011043352740 · Cited by 68
A U-Tetrad Stabilizes Human Telomeric RNA G-Quadruplex Structure
Xu, Y., Ishizuka, T., Kimura, T., & Komiyama, M. (2010) · Journal of the American Chemical Society · doi:10.1021/ja909708a · Cited by 67
Self-citationStructural identity of telomeric complexes
Giraud-Panis, M.-J. E., Pisano, S., Poulet, A., Du, M. L., & Gilson, É. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.08.004 · Cited by 67
TELOMERASE INHIBITORS – OLIGONUCLEOTIDE PHOSPHORAMIDATES AS POTENTIAL THERAPEUTIC AGENTS
Gryaznov, S. M., Pongracz, K., Matray, T. J., Schultz, R. G., Pruzan, R., Aimi, J., Chin, A., Harley, C. B., Herbert, B., Shay, J. W., et al. (2001) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1081/ncn-100002314 · Cited by 67
Bates, P. J., Mergny, J., & Yang, D. (2007) · EMBO Reports · doi:10.1038/sj.embor.7401073 · Cited by 66
Visualization of G-quadruplexes by using a BODIPY-labeled macrocyclic heptaoxazole
Tera, M., Iida, K., Ikebukuro, K., Seimiya, H., Shin‐ya, K., & Nagasawa, K. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c002117b · Cited by 64
Telomere dynamics in genome stability
Bhattacharyya, M. K., & Lustig, A. J. (2006) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2005.12.001 · Cited by 62
Human Telomeric DNA Sequence-Specific Cleaving by G-Quadruplex Formation
Xu, Y., Suzuki, Y., Lönnberg, T., & Komiyama, M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja807313x · Cited by 59
Self-citationMechanism-based combination telomerase inhibition therapy
Shay, J. W., & Wright, W. E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.12.012 · Cited by 58
Sequence specificity of inter‐ and intramolecular G‐quadruplex formation by human telomeric DNA
Pedroso, I. M., Duarte, L. F., Yanez, G., Burkewitz, K., & Fletcher, T. M. (2007) · Biopolymers · doi:10.1002/bip.20790 · Cited by 58
Telomere Biology in Heart Failure
Wong, L. S. M., de Boer, R. A., Samani, N. J., van Veldhuisen, D. J., & van der Harst, P. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.007 · Cited by 58
Fletcher, T. M., Cathers, B. E., Ravikumar, K. S., Mamiya, B. M., & Kerwin, S. M. (2001) · Bioorganic Chemistry · doi:10.1006/bioo.2000.1194 · Cited by 57
Woo, H. J., Lee, S., Choi, B. T., Park, Y., & Choi, Y. H. (2006) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2006.02.004 · Cited by 56
The p23 molecular chaperone promotes functional telomerase complexes through DNA dissociation
Toogun, O. A., Zeiger, W., & Freeman, B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701442104 · Cited by 55
The 5′-End of hTERT mRNA Is a Good Target for Hammerhead Ribozyme to Suppress Telomerase Activity
Yokoyama, Y., Takahashi, Y., Shinohara, A., Wan, X., Takahashi, S., Niwa, K., & Tamaya, T. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2939 · Cited by 54
Kim, J. H., Kim, J. H., Lee, G. E., Kim, S. W., & Chung, I. K. (2003) · Biochemical Journal · doi:10.1042/bj20030363 · Cited by 54
Protecting the terminus: t-loops and telomere end-binding proteins
Wei, C., & Price, C. M. (2003) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3244-z · Cited by 53
Elayadi, A. N., Demieville, A., Wancewicz, E. V., Monia, B. P., & Corey, D. R. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.8.1683 · Cited by 53
Stable Lariat Formation Based on a G-Quadruplex Scaffold
Xu, Y., Sato, H., Sannohe, Y., Shinohara, K., & Sugiyama, H. (2008) · Journal of the American Chemical Society · doi:10.1021/ja806535j · Cited by 51
Self-citationTreatment of bladder cancer cells in vitro and in vivo with 2–5A antisense telomerase RNA
Koga, S., Kondo, Y., Komata, T., & Kondo, S. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301449 · Cited by 51
Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides
Li, G., Eller, M. S., Hanna, K., & Gilchrest, B. A. (2004) · Experimental Cell Research · doi:10.1016/j.yexcr.2004.08.019 · Cited by 49
Komata, T., Kondo, Y., Koga, S., Ko, S.-C., Chung, L. W. K., & Kondo, S. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301327 · Cited by 49
Furan Based Cyclic Oligopeptides Selectively Target G-Quadruplex
Chakraborty, T. K., Arora, A., Roy, S., Kumar, N., & Maiti, S. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070619c · Cited by 48
Hasegawa, K., Ohashi, Y., Ishikawa, K., Yasue, A., Kato, R., Achiwa, Y., Nishio, E., & Udagawa, Y. (2005) · International Journal of Oncology · doi:10.3892/ijo.26.5.1419 · Cited by 48
Molecular targeting of cancer: Telomeres as targets
Hodes, R. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151267698 · Cited by 47
Telomerase immunity from bench to bedside: round one
Cortez-Gonzalez, X., & Zanetti, M. (2007) · Journal of Translational Medicine · doi:10.1186/1479-5876-5-12 · Cited by 45
Nakai, R., Ishida, H., Asai, A., Ogawa, H., Yamamoto, Y., Kawasaki, H., Akinaga, S., Mizukami, T., & Yamashita, Y. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2005.11.010 · Cited by 45
Telomerase targeted oligonucleotide thio‐phosphoramidates in T24‐luc bladder cancer cells
Dikmen, Z. G., Wright, W. E., Shay, J. W., & Gryaznov, S. M. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21635 · Cited by 43
Recent advances in the development of telomerase inhibitors for the treatment of cancer
Perry, P. J., & Jenkins, T. C. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.1981 · Cited by 42
Telomerase inhibitors: targeting the vulnerable end of cancer?
Kèlland, L. R. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200008000-00001 · Cited by 40
Artificial human telomeres from DNA nanocircle templates
Lindström, U. M., Chandrasekaran, R. A., Orbai, L., Helquist, S. A., Miller, G. P., Oroudjev, E., Hansma, H. G., & Kool, E. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252396199 · Cited by 40
Exploring the Recognition of Quadruplex DNA by an Engineered Cys2-His2 Zinc Finger Protein
Ladame, S., Schouten, J. A., Granadino‐Roldán, J. M., Redman, J. E., Neidle, S., & Balasubramanian, S. (2006) · Biochemistry · doi:10.1021/bi050229x · Cited by 38
Vitamin E suppresses telomerase activity in ovarian cancer cells
Bermudez, Y., Ahmadi, S., Lowell, N. E., & Kruk, P. A. (2007) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2006.12.002 · Cited by 37
Lysinyl macrocyclic hexaoxazoles: Synthesis and selective G-quadruplex stabilizing properties
Rzuczek, S. G., Pilch, D. S., LaVoie, E. J., & Rice, J. E. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.12.048 · Cited by 37
Incles, C. M., Schultes, C. M., Kèlland, L. R., & Neidle, S. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1101 · Cited by 35
Heald, R. A., & Stevens, M. F. G. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b305177n · Cited by 33
Role of hTERT in apoptosis of cervical cancer induced by histone deacetylase inhibitor
Wu, P., Li, M., Wang, H., Zhou, J., Xu, G., Wang, S., Xi, L., Chen, G., Wang, B., Zhu, T., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.07.039 · Cited by 33
First International Meeting on Quadruplex DNA
Wilson, W. D., & Sugiyama, H. (2007) · ACS Chemical Biology · doi:10.1021/cb7001686 · Cited by 32
Inhibition of human telomerase by PNA-cationic peptide conjugates
Harrison, J. G., Frier, C., Laurant, R., Dennis, R. L., Raney, K. D., & Balasubramanian, S. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00170-5 · Cited by 32
Telomere dynamics in Fancg-deficient mouse and human cells
Franco, S., van de Vrugt, H. J., Fernández, P., Aracil, M., Arwert, F., & Blasco, M. A. (2004) · Blood · doi:10.1182/blood-2003-10-3626 · Cited by 30
Multani, A. S., Furlong, C., & Pathak, S. (1998) · International Journal of Oncology · doi:10.3892/ijo.13.5.923 · Cited by 28
The telomere story or the triumph of an open-minded research
Gilson, É., & Ségal-Bendirdjian, E. (2010) · Biochimie · doi:10.1016/j.biochi.2009.12.014 · Cited by 28
Gomez, D. E., Kassim, A., & Olivero, O. A. (1995) · International Journal of Oncology · doi:10.3892/ijo.7.5.1057 · Cited by 26
Targeting Human Telomerase in Cancer Therapy
Huard, S., & Autexier, C. (2002) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011023353822 · Cited by 23
Design of Telomerase Inhibitors for the Treatment of Cancer
Cairns, D., Anderson, R. J., Perry, P. J., et al. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023392720 · Cited by 23
Targeting Telomerase via Its Key RNA/DNA Heteroduplex
Francis, R., West, C., & Friedman, S. H. (2001) · Bioorganic Chemistry · doi:10.1006/bioo.2000.1196 · Cited by 22
A 6-mer Photocontrolled Oligonucleotide as an Effective Telomerase Inhibitor
Xu, Y., Ito, K., Suzuki, Y., & Komiyama, M. (2009) · Journal of the American Chemical Society · doi:10.1021/ja907417r · Cited by 22
Self-citationThe telomerase challenge — an unusual problem in drug discovery
Pitts, A. E., & Corey, D. R. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01322-7 · Cited by 21
Cristofari, G., Sikora, K. O., & Lingner, J. (2007) · ACS Chemical Biology · doi:10.1021/cb700037c · Cited by 19
Telomerase targeting in cancer treatment: new developments
Helder, M. N., de Jong, S., de Vries, E. G. E., & van der Zee, A. G. J. (1999) · Drug Resistance Updates · doi:10.1054/drup.1999.0074 · Cited by 18
Recognition of 2′-Deoxy--ribonucleoside 5′-Triphosphates by Human Telomerase
Yamaguchi, T., Yamada, R., Tomikawa, A., Shudo, K., Saito, M., Ishikawa, F., & Saneyoshi, M. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3982 · Cited by 15
Meeting report: Second international meeting on quadruplex DNA
Herbert, B., Huppert, J. L., Johnson, F. B., Lane, A. N., & Phan, A. T. (2009) · Biochimie · doi:10.1016/j.biochi.2009.06.011 · Cited by 9
Azzalin, C. M., & Lingner, J. (2007) · Nature · doi:10.1038/4481001a · Cited by 6
Cited by
Wang, F., Lu, C.-H., & Willner, I. (2014) · Chemical Reviews · doi:10.1021/cr400354z · Cited by 649
Effects of Molecular Crowding on the Structures, Interactions, and Functions of Nucleic Acids
Nakano, S.-I., Miyoshi, D., & Sugimoto, N. (2014) · Chemical Reviews · doi:10.1021/cr400113m · Cited by 567
Bertrand, B., & Casini, A. (2014) · Dalton Trans. · doi:10.1039/c3dt52524d · Cited by 441
Becherer, L., Borst, N., Bakheit, M., Frischmann, S., Zengerle, R., & von Stetten, F. (2020) · Analytical Methods · doi:10.1039/c9ay02246e · Cited by 429
Novel anticancer therapeutics targeting telomerase
Ruden, M., & Puri, N. (2013) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.06.007 · Cited by 310
Metadata
- Authors
- Xu, Y.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2011
- Volume
- 40
- Issue
- 5
- Pages
- 2719
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2079954805
- Cited by
- 323
- References
- 360
- FWCI
- 3.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.